What are the strategic implications of this comparison

Assignment Help Financial Management

Reference no: EM132040990

Case Analysis:

Valeant Pharmaceuticals is a specialty drug manufacturer operating in the fast-cycle pharmaceutical industry. In this business, size often matters and Valeant, along with most of the major players in the industry, has aggressively utilized mergers and acquisitions to acquire R&D capabilities and other key strategic resources, create synergies, capture market share, and use acquired legacy products to support future growth. Valeant’s 2010 merger with Biovail Corp was designed with all of these benefits in mind. To develop an effective strategic position, Valeant must address several important external factors including the global economy, advances in technology, population demographics and sociocultural influences, and shifting political/legal forces that affect not only the drug approval process but also the changing nature of healthcare. To address these considerations, Valeant must develop strategies in the areas of marketing and sales, product innovation, operational speed and efficiency, and M&A to position itself for future success The purpose of this case study is to determine if the company’s recent merger with Biovail, other M&A’s and restructuring efforts will yield the benefits promised to shareholders and enable the firm to compete more effectively in the marketplace.To reasonably determine the merit of its strategic approach, external environmental trends, competitor positions, financial indicators, internal resources, and company strategies must be considered.The results of the analysis can then be used to suggest measures which can improve Valeant’s strategic position and potential for ongoing success.

Other pharmecautical competitors:

Accera, the company looking into the metabolic aspects of Alzheimer's, will have data coming out on its phase 3 trial in the first quarter of 2017.

Merck, which has a BACE inhibitor that works along the amyloid hypothesis, will have a phase 3 trial wrapping up in July 2017.

Axovant, whose drug aims to treat the symptoms of Alzheimer's, will have phase 3 data coming out in the second half of 2017.

Question:

Conduct a comparative analysis of the company’s primary competitors in the neurology division. What are the strategic implications of this comparison? What corrective actions are suggested?

Reference no: EM132040990

Questions Cloud

How much risk reduction could you achieve : How much risk reduction could you achieve, at no sacrifice in expected return, by making your portfolio an efficient one?

Write brief introduction discussing purpose of your group : First, write a brief introduction discussing the purpose of your group, a brief description of your group members and discussing the general tasks

What would be the npv of buying the points : What would be the NPV of buying the points if you expected to keep the house for at least 30 years (so that you would fully pay off the loan)?

Justify the assembly of a balanced product portfolio : Justify the assembly of a balanced product portfolio by marketing managers as a means of ensuring extended success in the health care market industry.

What are the strategic implications of this comparison : Conduct a comparative analysis of the company’s primary competitors in the neurology division. What are the strategic implications of this comparison?

Earn an annual rate of return : The scenario we are looking at is that we want to purchase a common stock and hold it for 7 years. Samsung just announce that they will be paying an annual cash

What is present value of net benefits associated this change : Assuming that the average driver drives the speed limit both before and after the change what is the present value of net benefits associated this change?

What study uses statistical testing : What study uses statistical testing? What are the statistical tests that are used? What do each ones allow the researchers to accomplish and/or conclude

Why is statistical testing important in research : There are strengths and weaknesses associated with statistical testing. Why is statistical testing important in research?

User Account

All Pages